title: Tumor necrosis factor inhibition as a novel treatment for refractory sarcoidosis.
authors.affiliation: University of Chicago, IL 60637, USA. nsweiss@medicine.bsd.uchicago.edu
authors.forename: Nadera J
authors.initials: NJ
authors.lastname: Sweiss
authors.forename: Michael Jude
authors.initials: MJ
authors.lastname: Welsch
authors.forename: James J
authors.initials: JJ
authors.lastname: Curran
authors.forename: Michael H
authors.initials: MH
authors.lastname: Ellman
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003879:Dermatologic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D012507:Sarcoidosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab